» Articles » PMID: 8948637

Regulation of the Double-stranded RNA-dependent Protein Kinase PKR by RNAs Encoded by a Repeated Sequence in the Epstein-Barr Virus Genome

Overview
Specialty Biochemistry
Date 1996 Nov 15
PMID 8948637
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

During the initial infection of B lymphocytes by Epstein-Barr virus (EBV) only a few viral genes are expressed, six of which encode the EBV nuclear antigens, EBNAs 1-6. The majority of EBNA mRNAs share common 5'-ends containing a variable number of two alternating and repeated exons transcribed from the BamHI W major internal repeats of the viral DNA. These sequences can also exist as independent small RNA species in some EBV-infected cell types. We present evidence that transcripts from these W repeat regions can exert a trans-acting effect on protein synthesis, through their ability to activate the dsRNA-dependent protein kinase PKR. UV cross-linking and filter binding assays have demonstrated that the W transcripts bind specifically to PKR and can compete with another EBV-encoded small RNA, EBER-1, which was shown previously to bind this kinase. In the reticulocyte lysate system the W RNAs shut off protein synthesis through an ability to activate PKR. In contrast to EBER-1, the W RNAs are unable to block the dsRNA-dependent activation of PKR. Using a purified preparation of the protein kinase we have shown that the W transcripts directly activate PKR in vitro. The results suggest that EBV has the ability both to activate and to inhibit PKR through the actions of different products of viral transcription.

Citing Articles

Signal transduction in the type I interferon system and viral countermeasures.

Brzozka K, Pfaller C, Conzelmann K Signal Transduct. 2020; 7(1):5-19.

PMID: 32327963 PMC: 7169511. DOI: 10.1002/sita.200600115.


Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma.

Farina A, Cirone M, York M, Lenna S, Padilla C, McLaughlin S J Invest Dermatol. 2013; 134(4):954-964.

PMID: 24129067 PMC: 3961515. DOI: 10.1038/jid.2013.423.


The innate antiviral immune system of the cat: molecular tools for the measurement of its state of activation.

Robert-Tissot C, Ruegger V, Cattori V, Meli M, Riond B, Gomes-Keller M Vet Immunol Immunopathol. 2011; 143(3-4):269-81.

PMID: 21719112 PMC: 7112645. DOI: 10.1016/j.vetimm.2011.06.005.


Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

George C, Li Z, Okonski K, Toth A, Wang Y, Samuel C J Interferon Cytokine Res. 2009; 29(9):477-87.

PMID: 19715457 PMC: 2956706. DOI: 10.1089/jir.2009.0065.


Epstein-Barr virus and Burkitt lymphoma.

Brady G, MacArthur G, Farrell P J Clin Pathol. 2007; 60(12):1397-402.

PMID: 18042696 PMC: 2095571. DOI: 10.1136/jcp.2007.047977.


References
1.
Kozak M . Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol Cell Biol. 1989; 9(11):5134-42. PMC: 363665. DOI: 10.1128/mcb.9.11.5134-5142.1989. View

2.
Woisetschlaeger M, Yandava C, Furmanski L, Strominger J, Speck S . Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci U S A. 1990; 87(5):1725-9. PMC: 53555. DOI: 10.1073/pnas.87.5.1725. View

3.
Rogers R, Woisetschlaeger M, Speck S . Alternative splicing dictates translational start in Epstein-Barr virus transcripts. EMBO J. 1990; 9(7):2273-7. PMC: 551952. DOI: 10.1002/j.1460-2075.1990.tb07398.x. View

4.
Clarke P, Sharp N, Arrand J, Clemens M . Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state. Biochim Biophys Acta. 1990; 1050(1-3):167-73. DOI: 10.1016/0167-4781(90)90161-t. View

5.
Mellits K, Peery T, Manche L, Robertson H, Mathews M . Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector. Nucleic Acids Res. 1990; 18(18):5401-6. PMC: 332216. DOI: 10.1093/nar/18.18.5401. View